These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 22198753

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. miR-363-3p is activated by MYB and regulates osteoporosis pathogenesis via PTEN/PI3K/AKT signaling pathway.
    Li M, Luo R, Yang W, Zhou Z, Li C.
    In Vitro Cell Dev Biol Anim; 2019 May; 55(5):376-386. PubMed ID: 31025251
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Vascular endothelial growth factor receptors in osteoclast differentiation and function.
    Aldridge SE, Lennard TW, Williams JR, Birch MA.
    Biochem Biophys Res Commun; 2005 Sep 30; 335(3):793-8. PubMed ID: 16105658
    [Abstract] [Full Text] [Related]

  • 29. MicroRNAs: Key Regulators to Understand Osteoclast Differentiation?
    Lozano C, Duroux-Richard I, Firat H, Schordan E, Apparailly F.
    Front Immunol; 2019 Sep 30; 10():375. PubMed ID: 30899258
    [Abstract] [Full Text] [Related]

  • 30. A potential therapeutic target for regulating osteoporosis via suppression of osteoclast differentiation.
    Sun Q, Zhang B, Zhu W, Wei W, Ma J, Tay FR.
    J Dent; 2019 Mar 30; 82():91-97. PubMed ID: 30716449
    [Abstract] [Full Text] [Related]

  • 31. MicroRNA-338-3p inhibits glucocorticoid-induced osteoclast formation through RANKL targeting.
    Zhang XH, Geng GL, Su B, Liang CP, Wang F, Bao JC.
    Genet Mol Res; 2016 Aug 26; 15(3):. PubMed ID: 27706599
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. miRNA-27a is essential for bone remodeling by modulating p62-mediated osteoclast signaling.
    Wang S, Maruyama EO, Martinez J, Lopes J, Hsu T, Wu W, Hsu W, Maruyama T.
    Elife; 2023 Feb 08; 12():. PubMed ID: 36752600
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. MicroRNAs in bone diseases.
    Gennari L, Bianciardi S, Merlotti D.
    Osteoporos Int; 2017 Apr 08; 28(4):1191-1213. PubMed ID: 27904930
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.